Healthcare Triangle, Inc. (NASDAQ: HCTI) has entered into an advance agreement to acquire the shares of Teyame 360 SL and Datono Mediacion SL, two Spain‑based companies that provide an AI‑powered omnichannel customer experience platform. The deal is valued at up to $50 million and will be financed with a mix of cash, HCTI common stock, non‑voting convertible preferred stock, and contingent earn‑out equity, with an expected closing in the first quarter of 2026 subject to customary conditions and shareholder approval.
The transaction is projected to add roughly $34 million in incremental annual revenue and $4.2 million in incremental EBITDA for fiscal year 2025. Those figures represent a dramatic upside relative to HCTI’s current top‑line of $11.70 million in 2024, a decline from prior years, and underscore the company’s intent to accelerate growth through AI‑enabled engagement tools.
Strategically, the acquisition expands HCTI’s portfolio beyond its existing CloudEz, DataEz, and Readabl.AI platforms. By integrating Teyame’s chatbot automation, multilingual patient engagement, and real‑time analytics capabilities, HCTI aims to create a unified, intelligent ecosystem that serves patients, providers, and global markets. The move signals a broader pivot toward comprehensive digital health innovation and a shift from traditional healthcare IT to AI‑driven customer and patient engagement.
HCTI’s recent financials paint a picture of a company in distress: revenue fell to $11.70 million in 2024, EPS for Q3 2025 was –$0.42, and trailing‑12‑month net income was –$6.3 million. The Altman Z‑Score of –1.93 indicates significant financial instability. The acquisition is therefore a high‑risk, high‑reward play that could potentially reverse the company’s negative trajectory if the AI platform gains traction.
CFO David Ayanoglou emphasized the strategic importance of the deal, stating, “The transaction will bring real‑world lived experience of Agentic Gen AI and is about to change the game for HCTI. It’s where the rubber meets the road in AI.” The quote highlights management’s confidence that the AI capabilities will unlock new revenue streams and improve operational efficiency.
While the deal offers a clear path to higher revenue and EBITDA, HCTI faces headwinds such as ongoing negative equity, a history of declining revenue, and a need to demonstrate that the AI platform can generate sustainable cash flow. The acquisition’s success will hinge on rapid integration, customer adoption, and the ability to convert the projected incremental revenue into profitable growth.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.